U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
179731179731Efficacy and Safety Study of Cilostazol to Prevent Reoccurrence of StrokeCompletedNo Results AvailableCerebral InfarctionDrug: Cilostazol 200mg/day Oral|Drug: Aspirin 100mg/day Oralhttps://ClinicalTrials.gov/show/NCT00202020
179732179732Efficacy and Safety Study of Aripiprazole to Treat SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Aripiprazole tablet, 5-30mg/day, oral, 6 weeks|Drug: Risperidone tablet, 1-6mg/day, oral, 6 weekshttps://ClinicalTrials.gov/show/NCT00202007
179733179733"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in HyponatremiaCompletedNo Results AvailableHyponatremia|Water Intoxication|Inappropriate ADH Syndrome|Water-electrolyte ImbalanceDrug: Tolvaptanhttps://ClinicalTrials.gov/show/NCT00201994
179734179734Study of Rebamipide Eye Drops to Treat Dry EyeCompletedNo Results AvailableKeratoconjunctivitis SiccaDrug: Rebamipidehttps://ClinicalTrials.gov/show/NCT00201981
179735179735Functional Electrical Stimulation-Assisted Walking: Reduction of Secondary Complications Due to Spinal Cord InjuryActive, not recruitingNo Results AvailableSpinal Cord InjuryDevice: Compex Motion Stimulator|Device: Compex Motion Stimulator|Other: Conventional Exercisehttps://ClinicalTrials.gov/show/NCT00201968
179736179736Study of Rebamipide Eye Drops to Treat Dry EyeCompletedNo Results AvailableKeratoconjunctivitis SiccaDrug: Rebamipidehttps://ClinicalTrials.gov/show/NCT00201955
179737179737PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)CompletedNo Results AvailableBreast CancerProcedure: PET scanhttps://ClinicalTrials.gov/show/NCT00201942
179738179738A Decision Aid for Women With Early Stage Breast CancerCompletedNo Results AvailableBreast CancerProcedure: Standard Decision Board|Procedure: Computer Decision Board|Procedure: Paper Decision Boardhttps://ClinicalTrials.gov/show/NCT00201929
179739179739Shorter Radiation Schedule for the Treatment of Prostate CancerCompletedNo Results AvailableProstate CancerProcedure: 5250 cGy/20 fractions over 28 days|Procedure: 6600 cGy/33 fractions over 45 dayshttps://ClinicalTrials.gov/show/NCT00201916
179740179740The Roles of Tissue Factor in Malignant GliomasCompletedNo Results AvailableVenous Thromboembolism|Brain Tumorshttps://ClinicalTrials.gov/show/NCT00201903
179741179741Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"CompletedNo Results AvailableBreast Cancer|LymphedemaProcedure: Lymphatic Massage (Decongestive Lymphatic Therapy) (Arm 1)https://ClinicalTrials.gov/show/NCT00201890
179742179742Velcade (Bortezomib, PS-341) and Rituximab in Relapsed/Refractory Mantle Cell and Follicular Non-Hodgkin's LymphomaCompletedHas ResultsNon-Hodgkin's Lymphoma|Mantle Cell LymphomaDrug: Velcade|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00201877
179743179743Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Exemestane|Drug: Fulvestranthttps://ClinicalTrials.gov/show/NCT00201864
179744179744Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast CancerCompletedHas ResultsBreast CancerDrug: Tamoxifen|Procedure: Surgery: Oophorectomyhttps://ClinicalTrials.gov/show/NCT00201851
179745179745Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic AdenocarcinomaCompletedHas ResultsPancreatic Neoplasms|AdenocarcinomaDrug: Gemcitabine|Drug: Etanercepthttps://ClinicalTrials.gov/show/NCT00201838
179746179746A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer PatientsCompletedHas ResultsLung Cancer|Non-Small-Cell Lung CarcinomaDrug: Capecitabine|Drug: Docetaxelhttps://ClinicalTrials.gov/show/NCT00201825
179747179747Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid TumorsCompletedNo Results AvailableTumorsDrug: Etanercept|Drug: Docetaxel|Drug: Dexamethasonehttps://ClinicalTrials.gov/show/NCT00201812
179748179748Infliximab for the Prevention of Graft-versus-Host Disease Following Allogenic Hematopoietic Stem Cell TransplantationCompletedNo Results AvailableGraft-Versus-Host DiseaseDrug: Infliximabhttps://ClinicalTrials.gov/show/NCT00201799
179749179749Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host DiseaseCompletedNo Results AvailableGraft-Versus-Host DiseaseDrug: Pentostatinhttps://ClinicalTrials.gov/show/NCT00201786
179750179750Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast CancerCompletedHas ResultsBreast CancerDrug: Exemestane|Drug: Celecoxib|Other: Correlative studieshttps://ClinicalTrials.gov/show/NCT00201773
179751179751Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast CancerActive, not recruitingNo Results AvailableBreast CancerDrug: Gemcitabine|Drug: Trastuzumab|Drug: Cisplatinhttps://ClinicalTrials.gov/show/NCT00201760
179752179752Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach CancerCompletedNo Results AvailableEsophageal Cancer|Esophagus Cancer|Cancer of Stomach|Stomach CancerDrug: CPT-11|Drug: Mitomycin Chttps://ClinicalTrials.gov/show/NCT00201747
179753179753Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown PrimaryActive, not recruitingNo Results AvailableTumors|Unknown Primary Tumors|AdenocarcinomaDrug: Capecitabine|Drug: Carboplatin|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT00201734
179754179754Pentostatin, and Rituximab With and Without Cyclophosphamide for Previously Untreated B-Chronic Lymphocytic LeukemiaActive, not recruitingNo Results AvailableB-Chronic Lymphocytic LeukemiaDrug: Pentostatin|Drug: Rituximab|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00201721
179755179755Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast CancerCompletedNo Results AvailableBreast CancerDrug: Docetaxel|Drug: Doxorubicin|Drug: Cyclophosphamide (AC)https://ClinicalTrials.gov/show/NCT00201708
179756179756Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple MyelomaCompletedNo Results AvailableMultiple MyelomaDrug: Doxil®|Drug: Vincristine|Drug: Dexamethasone|Drug: Arsenic Trioxidehttps://ClinicalTrials.gov/show/NCT00201695
179757179757Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCompletedNo Results AvailableChronic Lymphocytic Leukemia|Small Lymphocytic LymphomaDrug: Etanercept|Drug: Rituximabhttps://ClinicalTrials.gov/show/NCT00201682
179758179758A Phase II Study of Clofarabine in Patients With Aggressive Non-Hodgkin's LymphomaCompletedNo Results AvailableNon-Hodgkin's LymphomaDrug: Clofarabinehttps://ClinicalTrials.gov/show/NCT00201669
179759179759Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)TerminatedNo Results AvailableFetal Membranes, Premature RuptureProcedure: Retention of Cerclage|Procedure: Removal of Cerclage|Procedure: Removal vs. Retention of Cervical Cerclagehttps://ClinicalTrials.gov/show/NCT00201656
179760179760A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal OutcomeCompletedHas ResultsPreterm DeliveryDrug: Betamethasone or Dexamethasone (2nd course of ACS)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00201643

* Görseller ve İçerik tekif hakkına sahip olabilir